A single in vivo administration of bombesin antagonist RC-3095 reduces the levels and mRNA expression of epidermal growth factor receptors in MXT mouse mammary cancers

Epidermal growth factor (EGF) and its receptors (EGFR) play important roles in tumorigenesis. In various experimental cancers, treatment with antagonists of bombesin/gastrin-releasing peptide (BN/GRP) produces a reduction in EGFRs, concomitant to inhibition of tumor growth. To investigate the mechan...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Proc Natl Acad Sci U S A
Principais autores:	Szepeshazi, Karoly, Schally, Andrew V., Halmos, Gabor, Lamharzi, Najib, Groot, Kate, Horvath, Judit E.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	National Academy of Sciences 1997
Assuntos:	Biological Sciences
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC23529/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9380734/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.94.20.10913
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!